Li Zhiqiang, Wu Shuhui, Liang Fang, Tan Fengjiao, Li Ning, Bao Mengxin
Department of Neurology, Liaocheng People's Hospital, Liaocheng, Shandong, China.
Department of Traditional Chinese Medicine, Liaocheng Third People's Hospital, Liaocheng, Shandong, China.
Front Neurol. 2023 Jul 12;14:1227642. doi: 10.3389/fneur.2023.1227642. eCollection 2023.
Endovascular thrombectomy (EVT) has evolved into the standard treatment for patients with acute ischemic stroke (AIS) and large vessel occlusion (LVO). However, little information is available on the management of EVT in young patients with AIS-LVO in China. The purpose of this study was to assess the favorable outcomes and mortality rates after 90 days of EVT in young Chinese patients with AIS-LVO and their predictors.
This retrospective study included young Chinese patients aged 18-50 years with AIS-LVO. The primary efficacy endpoint was the modified Rankin scale (mRS) score at day 90, and the primary safety endpoint was mortality within 90 days. Using univariate and multivariate logistic regression analyses, the associations between clinical, imaging, and procedure variables and favorable (mRS 0-2) outcomes or mortality at 90 days were analyzed.
A total of 113 patients were included in the study with a mean age of 43.1 ± 6.3 years. Symptomatic intracranial hemorrhage (sICH) occurred in 8 (7.1%) patients. Favorable functional outcomes (mRS 0-2) were recovered in 42.5% of patients at 3 months. After 90 days, the mortality rate was 32.3%. Multivariate analysis revealed that the increase in admission NIHSS score was associated with a lower probability of functional independence (aOR 1.08, 95% CI 1.02-1.15, = 0.01 and aOR 1.01, 95% CI 1-1.01, = 0.008, respectively) and a higher probability of death at 90 days (aOR 1.1, 95% CI 1.03-1.18, = 0.007 and aOR 1.00, 95% CI 1-1.01, = 0.021, respectively).
This study demonstrate that EVT provides higher rates of arterial recanalization, rather than better favorable outcomes and lower risk of death at 3 months in young Chinese patients with AIS-LVO. Increased NIHSS scores on admission may be associated with poor patient prognosis.
血管内血栓切除术(EVT)已发展成为急性缺血性卒中(AIS)合并大血管闭塞(LVO)患者的标准治疗方法。然而,在中国,关于年轻AIS-LVO患者的EVT治疗管理的信息较少。本研究的目的是评估中国年轻AIS-LVO患者接受EVT治疗90天后的良好预后和死亡率及其预测因素。
这项回顾性研究纳入了年龄在18至50岁之间的中国年轻AIS-LVO患者。主要疗效终点是90天时的改良Rankin量表(mRS)评分,主要安全终点是90天内的死亡率。使用单因素和多因素逻辑回归分析,分析临床、影像和手术变量与90天时良好(mRS 0-2)预后或死亡率之间的关联。
本研究共纳入113例患者,平均年龄为43.1±6.3岁。8例(7.1%)患者发生有症状颅内出血(sICH)。3个月时,42.5%的患者获得了良好的功能预后(mRS 0-2)。90天后,死亡率为32.3%。多因素分析显示,入院时NIHSS评分增加与功能独立的可能性降低(调整后比值比分别为1.08,95%可信区间1.02-1.15,P=0.01和1.01,95%可信区间1-1.01,P=0.008)以及90天时死亡的可能性增加(调整后比值比分别为1.1,95%可信区间1.03-1.18,P=0.007和1.00,95%可信区间1-1.01,P=0.021)相关。
本研究表明,对于中国年轻AIS-LVO患者,EVT可实现更高的动脉再通率,但在3个月时并不能带来更好的良好预后和更低的死亡风险。入院时NIHSS评分升高可能与患者预后不良相关。